Date of response: 12 February 2026

Outcome: Information partially disclosed

Category: Medicines Optimisation

Request

Funding mechanisms, contractual arrangements and provider payment for medical retina (anti-VEGF) drugs

ICB Response

NN ICB 26 1467 Response Letter Final

pdf (260K)

Close
Search